Express Pharma
NOVEMBER 15, 2024
Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in It meets the healthcare needs of over 1.4
Quality Matters
JANUARY 23, 2023
Leveraging insights from data on USP standards distribution and usage at more than 22,000 locations worldwide and 40+ external data sets, USP launched the Medicine Supply Map in 2021 to provide an early-warning capability for supply chain vulnerabilities.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Quality Matters
APRIL 18, 2024
Agency for International Development (USAID) and others, we strengthened 22 national medicines regulatory authorities, supported 23 national control and diagnostic laboratories to meet global standards, and advanced quality production with 36 manufacturers for 50 medical products. These USP documentary standards are recognized in U.S.
Quality Matters
OCTOBER 13, 2021
With this extensive system in place, patients can trust that medicines with the same name will be consistent in quality no matter who manufactures it or where in the world it is made. Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient.
Quality Matters
SEPTEMBER 15, 2023
For example, while some stakeholders may perceive PCM to be primarily for innovators and not for makers of generic medicines or biotech companies, it “can be for generic companies, biotechnology companies, and so on, and we have had engagements with generic drug companies in our emerging technologies program already,” Fisher said.
Express Pharma
MARCH 12, 2025
The FDA has an established office in India overseeing the number of qualified manufacturers supplying generic medicines to the US. In the last decade, there has been increased engagement between Indian pharmaceutical manufacturers and the FDA to address manufacturing and quality operations.
Quality Matters
MAY 18, 2023
government’s fiscal 2023 funding bill , signed into law in December 2022, included a range of specific provisions to support medicines supply chain resilience, including those supporting development of AMT through creation of national centers of excellence. The non-profit maker of essential generic medicines was established by a group of U.S.
Expert insights. Personalized for you.
102 
Let's personalize your content